Studies on intestinal absorption of sulpiride (1): Carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 7, 2002, Pages 885-890

  Watanabe, Kasuhiro ^a   Sawano, Tetsuya ^a   Terada, Kazuaya ^a   Endo, Tetsuya ^b   Sakata, Masakatsu ^b   Sato, Juichi ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Caco 2 cell; Organic cation transporter; P glycoprotein; PEPT1; Sulpiride; Uptake

Indexed keywords

CATION TRANSPORT PROTEIN; GLYCOPROTEIN P; ISOPROTEIN; NEUROLEPTIC AGENT; PEPTIDE TRANSPORTER 1; PLASTIC; PROTEIN INHIBITOR; PROTEINASE; SULPIRIDE; CARRIER PROTEIN; COTRANSPORTER; DOPAMINE RECEPTOR BLOCKING AGENT; MEMBRANE PROTEIN; ORGANIC CATION TRANSPORTER; SLC15A1 PROTEIN, HUMAN; SLC22A4 PROTEIN, HUMAN; SLC22A5 PROTEIN, HUMAN;

ACIDITY; ARTICLE; DRUG DETERMINATION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE CELL; LOW TEMPERATURE PROCEDURES; MONOLAYER CULTURE; TEMPERATURE DEPENDENCE; ACTIVE TRANSPORT; CELL STRAIN CACO 2; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PH; TEMPERATURE; TIME;

BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CARRIER PROTEINS; DOPAMINE ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; P-GLYCOPROTEIN; SULPIRIDE; SYMPORTERS; TEMPERATURE; TIME FACTORS;

EID: 0036632950     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.885     Document Type: Article

References (37)

1. Trabucchi M., Longoni R., Fresia P., Spano P. F., Life Sci., 17, 1551-1556 (1975).
2. Jenner P., Marsden C. D., Neuropharmacology, 20, 1285-1293 (1981).
3. Kohri N., Naasani I., Iseki K., Miyazaki K., J. Pharm. Pharmacol., 48, 371-374 (1996).
4. Naasani I., Kohri N., Iseki K., Miyazaki K., J. Pharm. Pharmacol., 47, 469-473 (1995).
5. Tsuji A., Tamai I., Pharm. Res., 13, 963-977 (1996).
6. Oh D. M., Han H. K., Amidon, G. L., Pharm. Biotechnol., 12, 59-88 (1999).
7. Endou H., Folia Pharmacol. Jpn., 116, 114-124 (2000).
8. Koepsell H., Annu. Rev. Physiol., 60, 243-266 (1998).
9. Meredith D., Boyd C. A. R., Cell. Mol. Life Sci., 57, 754-778 (2000).
10. Lee V. H. L., Eur. J. Pharm. Sci., 11 (Suppl. 2), S41-S50 (2000).
11. Terada T., Saito H., Inui K., J. Biol. Chem., 273, 5582-5585 (1998).
12. Saito H., Terada T., Okuda M., Sasaki S., Inui K., Biochim. Biophys. Acta, 1280, 173-177 (1996).
13. Balimane P. V., Tamai I., Guo A., Nakanishi T., Kitada H., Leibach F. H., Tsuji A., Sinko P. J., Biochem. Biophys. Res. Commun., 250, 246-251 (1998).
14. Boll M., Markovich D., Weber W. M., Korte H., Daniel H., Murer H., Pflugers Arch., 429, 146-149 (1994).
15. Tsuji A., Takanaga H., Tamai I., Terasaki T., Pharm. Res., 11, 30-37 (1994).
16. Artursson P., Karlsson J., Biochem. Biophys. Res. Commun., 175, 880-885 (1991).
17. Terada T., Sawada K., Saito H., Hashimoto Y., Inui K., Eur. J. Pharmacol., 392, 11-17 (2000).
18. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
19. Mizuno N., Morita E., Nishikata M., Shinkuma D., Yamanaka Y., Arch. Int. Pharmacodyn. Ther., 283, 30-38 (1986).
20. Yamada I., Mizuta H., Ogawa K., Tahara T., Chem. Pharm. Bull., 38, 2552-2555 (1990).
21. Bateman D. N., Adv. Biochem. Psychopharmacol., 35, 143-162 (1982).
22. Mizuuchi H., Katsura T., Hashimoto Y., Inui K., Pharm. Res., 17, 539-545 (2000).
23. Nakayama A., Saitoh H., Oda M., Takada M., Aungst B. J., Eur. J. Pharm. Sci., 11, 317-324 (2000).
24. Wu X., Huang W., Prasad P. D., Seth P., Rajan D. P., Leibach F. H., Chen J., Conway S. J., Ganapathy V., Pharmacology, 290, 1482-1492 (1999).
25. Yabbuchi H., Tamai I., Nezu J., Sakamoto K., Oku A., Shimane M., Sai Y., Tsuji A., J. Pharmacol. Exp. Ther., 289, 768-773 (1999).
26. Saeki T., Ueda K., Tanagawara Y., Hori R., Komano T., J. Biol. Chem., 268, 6077-6080 (1993).
27. Takeuchi A., Masuda S., Saito H., Hashimoto Y., Inui K., J. Pharmacol. Exp. Ther., 293, 1034-1039 (2000).
28. Uwai Y., Saito H, Hashimoto Y., Inui K., Eur. J. Pharmacol., 398, 193-197 (2000).
29. Zhang L., Gorset W., Dresser M. J., Giacomini K. M., J. Pharmacol. Exp. Ther., 288, 1192-1198 (1999).
30. Fujita T., Morishita Y., Ito H., Kuribayashi D., Yamamoto A., Muranishi S., Life Sci., 61, 2455-2465 (1997).
31. Kekuda R., Prasad P. D., Wu P., Wang H., Fei Y. J., Leibach F. H., Ganapathy V., J. Biol. Chem., 273, 15971-15979 (1998).
32. Tamai I., Yakugaku Zasshi, 117, 415-434 (1997).
33. Yabuuchi H., Tamai I., Sai Y., Tsuji A., Pharm. Res., 15, 411-416 (1998).
34. Weinberg S. L., Burckhardt G., Wilsom F. A., J. Clin. Invest., 78, 44-50 (1986).
35. Leier I., Hummel-Eisenbeiss J., Cui Y., Keppler D., Kidney Int., 57, 1636-1642 (2000).
36. Wandel C., Kim R. B., Kajiji S., Guengerich F. P., Wilkinson G. R., Wood A. J., Cancer Res., 59, 3944-3948 (1999).
37. Baluom M., Friedman M., Rubinstein A., J. Contr. Rel., 70, 139-147 (2001).